International Conference on Neuroprotective Agents

14th ICNA Conference

The Stanley Heritage Hotel, Estes Park, Colorado

October 28 - 31, 2018

Abstract Submission and Presentations

Each participant giving a platform presentation is expected to submit a manuscript, preferably at the time of the conference .  Participants giving a poster presentation may submit a manuscript if they so desire.  Both abstract and manuscript submissions are subject to peer review.  

Abstracts must be submitted as an email attachment: single-page Microsoft Word compatible document (text < 350 words, 12-point font, Times New Roman preferred).  The title should be boldface, and all authors’ affiliations included.  The email should include the corresponding and presenting author’s contact information (email address, fax, phone).  Choice of platform or poster presentation should be stated.  

Platform presentations will be 15 min + 5 min for discussion. All presentations should be limited to original work not previously published elsewhere.  

Abstract Submission Deadline (Oral):                                                                     September 10, 2018  

Abstract Submission Deadline (Poster):                                                                September 10, 2018  

 

Please send an e-mail with the abstract as an attachment in Microsoft Word to:

 Russell Andrews (rja@russelljandrews.org)        

Tucker Patterson (tucker.patterson @fda.hhs.gov)       

 

 Please indicate your preference for either a poster or platform presentation on your abstract